Prognosis of metastatic giant cell tumor of bone in the pre-denosumab era. A systematic review and a meta-analysis | ||
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández" | |
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández" | |
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández" | |
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández" | |
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández" | |
| dc.conicet.organizacion | Instituto de Efectividad Clínica y Sanitaria | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.contributor.author | Itkin, Boris | |
| dc.contributor.author | Straminsky, Samanta | |
| dc.contributor.author | De Ronato, Gabriela | |
| dc.contributor.author | Lewi, Daniel | |
| dc.contributor.author | Marantz, Adolfo | |
| dc.contributor.author | Bardach, Ariel Esteban | |
| dc.date.issued | 2018-07 | |
| dc.description.abstract | Background: Data on long-term prognosis of metastatic GCT (mGCT) is scant. The frequency of spontaneous regressions (SRs) is unknown. We aimed to estimate the prognosis of mGCT. Methods: We searched electronic scientific literature databases and generic Internet from January 1980 to August 2017. After identifying eligible studies we performed descriptive analyses and meta-analyses to estimate overall survival (OS), disease specific survival (DSS) and frequency of SRs in the years before the widespread use of denosumab. We performed pre-specified subgroup analyses of studies published before and after 2000 and of those with more and less than 10 years of follow-up. Results: After retrieving and combining data from 26 relevant retrospective case-series totaling 242 patients with a median follow-up of 6.9 years, the estimated pooled OS was 86.9% (95% CI 78.0-94.2). Pooled DSS was 88.0% (95% CI 79.7-94.7). SRs were observed in 4.5% of patients. In the subgroup of studies published after 2000 mGCT was the only cause of death of affected subjects. In case-series with a follow-up longer than 10 years pooled DSS was 69.7% (95% CI 25.5-99.8). Conclusions: To our knowledge this is the first study to derive estimated pooled OS and DSS of mGCT based on a large dataset. SRs were not exceptional phenomena. In a long run the disease could impact in a significant way on the life expectancy of affected subjects. | es |
| dc.description.fil | Fil: Itkin, Boris. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; Argentina | |
| dc.description.fil | Fil: Straminsky, Samanta. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; Argentina | |
| dc.description.fil | Fil: De Ronato, Gabriela. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; Argentina | |
| dc.description.fil | Fil: Lewi, Daniel. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; Argentina | |
| dc.description.fil | Fil: Marantz, Adolfo. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; Argentina | |
| dc.description.fil | Fil: Bardach, Ariel Esteban. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Itkin, Boris; Straminsky, Samanta; De Ronato, Gabriela; Lewi, Daniel; Marantz, Adolfo; et al.; Prognosis of metastatic giant cell tumor of bone in the pre-denosumab era. A systematic review and a meta-analysis; Oxford University Press; Japanese Journal Of Clinical Oncology; 48; 7; 7-2018; 640-652 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0368-2811 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/96640 | |
| dc.journal.ciudad | Oxford | es |
| dc.journal.number | 7 | es |
| dc.journal.pagination | 640-652 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Japanese Journal Of Clinical Oncology | es |
| dc.journal.volume | 48 | es |
| dc.language.iso | eng | es |
| dc.publisher | Oxford University Press | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://academic.oup.com/jjco/advance-article/doi/10.1093/jjco/hyy067/4993244 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1093/jjco/hyy067 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | LUNG-MED | es |
| dc.subject | LUNG-SURG | es |
| dc.subject | ORTHOPEDICS/SARCOMA | es |
| dc.subject.classification | Otras Ciencias Médicas | es |
| dc.subject.classification | Otras Ciencias Médicas | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Prognosis of metastatic giant cell tumor of bone in the pre-denosumab era. A systematic review and a meta-analysis | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.a035f286-5a43-4c34-ac23-e91a6aae3e1b_A.pdf
- Tamaño:
- 1.23 MB
- Formato:
- Adobe Portable Document Format
- Descripción: